ATE507837T1 - Behandlung von krebs mit natürlichen pflanzenprodukten, etherischen ölen oder inhaltsstoffen von pistazia arten - Google Patents

Behandlung von krebs mit natürlichen pflanzenprodukten, etherischen ölen oder inhaltsstoffen von pistazia arten

Info

Publication number
ATE507837T1
ATE507837T1 AT04022793T AT04022793T ATE507837T1 AT E507837 T1 ATE507837 T1 AT E507837T1 AT 04022793 T AT04022793 T AT 04022793T AT 04022793 T AT04022793 T AT 04022793T AT E507837 T1 ATE507837 T1 AT E507837T1
Authority
AT
Austria
Prior art keywords
species
pistachi
ingredients
treating cancer
essential oils
Prior art date
Application number
AT04022793T
Other languages
English (en)
Inventor
Regazzo Maria Paola Belloni
Original Assignee
Data Medica Padova S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Data Medica Padova S P A filed Critical Data Medica Padova S P A
Application granted granted Critical
Publication of ATE507837T1 publication Critical patent/ATE507837T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04022793T 2003-10-02 2004-09-24 Behandlung von krebs mit natürlichen pflanzenprodukten, etherischen ölen oder inhaltsstoffen von pistazia arten ATE507837T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/676,101 US20050074509A1 (en) 2003-10-02 2003-10-02 Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components

Publications (1)

Publication Number Publication Date
ATE507837T1 true ATE507837T1 (de) 2011-05-15

Family

ID=34314017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04022793T ATE507837T1 (de) 2003-10-02 2004-09-24 Behandlung von krebs mit natürlichen pflanzenprodukten, etherischen ölen oder inhaltsstoffen von pistazia arten

Country Status (5)

Country Link
US (2) US20050074509A1 (de)
EP (1) EP1520585B1 (de)
AT (1) ATE507837T1 (de)
DE (1) DE602004032502D1 (de)
ES (1) ES2366152T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326518D0 (en) * 2003-11-13 2003-12-17 Compton Developments Ltd Anti-cancer compounds
TR201911270T4 (tr) 2009-03-04 2019-08-21 Regenera Pharma Ltd Polimerik mirsen bileşimleri.
DK2403505T3 (en) 2009-03-04 2017-03-06 Regenera Pharma Ltd Therapeutic Applications of Mastic Rubber Fractions
PL2613777T3 (pl) 2010-09-07 2019-10-31 Regenera Pharma Ltd Kompozycje zawierające kwasowe ekstrakty mastyksu
IL237621A0 (en) 2015-03-08 2015-06-30 Regenera Pharma Ltd Use of isolated fractions of the gum goddess to treat optic neuropathy
WO2018047176A1 (en) 2016-09-08 2018-03-15 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy
EA201990560A1 (ru) 2016-09-08 2019-09-30 Регенера Фарма Лтд. Композиции, содержащие тритерпеноиды, и их применение для лечения оптической нейропатии
IT201700016726A1 (it) 2017-02-15 2018-08-15 Phytoitalia Srl Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
US10143197B1 (en) * 2017-07-12 2018-12-04 Mamoudou Setamou Insect attractants
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
CN116637092A (zh) * 2023-06-28 2023-08-25 首都医科大学附属北京世纪坛医院 柠檬烯作为胱硫醚-β-合成酶抑制剂中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
GR1003868B (el) * 2001-02-06 2002-04-19 Lavipharm S.A. Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
EP1501527B1 (de) 2002-05-01 2009-09-02 Lavipharm S.A. Verwendung von mastix und dessen ätherischen ölen zur verhinderung oder bekämpfung von mikrobieller infektionen
JP2004083443A (ja) * 2002-08-23 2004-03-18 Hideji Watanabe マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法

Also Published As

Publication number Publication date
EP1520585B1 (de) 2011-05-04
ES2366152T3 (es) 2011-10-17
US20050074509A1 (en) 2005-04-07
EP1520585A1 (de) 2005-04-06
HK1075825A1 (en) 2005-12-30
US20050163876A1 (en) 2005-07-28
DE602004032502D1 (de) 2011-06-16

Similar Documents

Publication Publication Date Title
DE602004032502D1 (de) Behandlung von Krebs mit natürlichen Pflanzenprodukten, etherischen Ölen oder Inhaltsstoffen von Pistazia Arten
UA92140C2 (ru) Способ экстракции предшественников химиопротекторов из семян и ростков растений семейства крестоцветных, экстракт с повышенным содержанием предшественника химиопротектора и пищевой продукт на основе экстракта
EP1594441A4 (de) Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor-antagonisten und eines nsaid und diese enthaltende zusammensetzung
ATE460164T1 (de) Mittel zur behandlung von hyperlipidämie mit pitavastatinen und eicosapentaensäure
WO2002038141A3 (en) Compositions and methods for treatment of mild cognitive impairment
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
WO2004103294A3 (en) Methods and compositions for the prevention and treatment of sepsis
DE60237115D1 (de) Synergistische Kombination von (-) -Gossypol mit Docetaxel oder Paclitaxel zur Behandlung von Krebs.
DE60126829D1 (de) Kombination von drei Substanzen zur Vorbeugung und Behandlung von Arthritis
ATE459353T1 (de) Gaboxadol zur behandlung von depressionen und anderen affektiven störungen
WO2019093673A3 (ko) 골질환 예방 또는 치료용 약학 조성물
WO2005053710A3 (en) Food composition comprising glucosamine
TW200727894A (en) Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation
PH12022552447A1 (en) Nlrp3 modulators
DE602005008241D1 (de) Zusammensetzung mit einem survivin-antisense-oligonucleotid und gemcitabin zur behandlung von krebs
ATE318610T1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
ATE360442T1 (de) Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen
MX2022005901A (es) Composiciones y métodos para el tratamiento de la enfermedad de huanglongbing en cítricos.
TW200628473A (en) Novel heterocycles
MX2021008780A (es) Métodos para identificar a un animal de compañía susceptible al tratamiento que reduce el riesgo de formación de cálculos y composiciones para reducir dicho riesgo.
ATE406169T1 (de) Verwendung von bananenextrakt zur behandlung von entzündlicher darmkrankheit
DE602004005455D1 (de) Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
EA201071377A1 (ru) Композиции на основе растений и их применение
EP4534146A3 (de) Dimenhydrinat und calciumpantothenat zur prävention und behandlung von muskelerkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1520585

Country of ref document: EP